Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Cotton

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Early Intervention in Psychiatry|July 4, 2018
Vocational engagement among young people entering mental health treatment compared with their general population peersEmma Caruana, John Farhall, Susan M Cotton, et al.
Schizophrenia Research|August 4, 2017
Pre-onset risk characteristics for mania among young people at clinical high risk for psychosisAswin Ratheesh, Susan M Cotton, Christopher G Davey, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 23, 2020
Adjunctive <i>Garcinia mangostana</i> Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placeboAlyna Turner, Andrea Baker, Olivia M Dean, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|March 26, 2019
Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive <i>Garcinia mangostana</i>Linn. (Mangosteen) Pericarp for SchizophreniaAlyna Turner, John J McGrath, Olivia M Dean, et al.
Psychiatry Research|January 26, 2015
The impact of neuropsychological functioning and coping style on perceived stress in individuals with first-episode psychosis and healthy controlsKelly A Allott, Marta Rapado-Castro, Tina-Marie Proffitt, et al.
Schizophrenia Research|August 14, 2013
The relative contribution of neurocognition and social cognition to 6-month vocational outcomes following Individual Placement and Support in first-episode psychosisKelly A Allott, Susan M Cotton, Gina L Chinnery, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 24, 2017
Staging in bipolar disorder: from theoretical framework to clinical utilityMichael Berk, Robert Post, Aswin Ratheesh, et al.
BMC Medicine|January 26, 2019
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placeboMichael Berk, Alyna Turner, Gin S Malhi, et al.
BMC Medicine|February 18, 2019
Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placeboMichael Berk, Alyna Turner, Gin S Malhi, et al.
Early Intervention in Psychiatry|July 16, 2013
A randomized controlled trial of vocational intervention for young people with first-episode psychosis: methodEóin Killackey, Kelly Allott, Susan M Cotton, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Early Intervention in Psychiatry|July 4, 2018
Vocational engagement among young people entering mental health treatment compared with their general population peersEmma Caruana, John Farhall, Susan M Cotton, et al.
Schizophrenia Research|August 4, 2017
Pre-onset risk characteristics for mania among young people at clinical high risk for psychosisAswin Ratheesh, Susan M Cotton, Christopher G Davey, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 23, 2020
Adjunctive <i>Garcinia mangostana</i> Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placeboAlyna Turner, Andrea Baker, Olivia M Dean, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|March 26, 2019
Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive <i>Garcinia mangostana</i>Linn. (Mangosteen) Pericarp for SchizophreniaAlyna Turner, John J McGrath, Olivia M Dean, et al.
Psychiatry Research|January 26, 2015
The impact of neuropsychological functioning and coping style on perceived stress in individuals with first-episode psychosis and healthy controlsKelly A Allott, Marta Rapado-Castro, Tina-Marie Proffitt, et al.
Schizophrenia Research|August 14, 2013
The relative contribution of neurocognition and social cognition to 6-month vocational outcomes following Individual Placement and Support in first-episode psychosisKelly A Allott, Susan M Cotton, Gina L Chinnery, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 24, 2017
Staging in bipolar disorder: from theoretical framework to clinical utilityMichael Berk, Robert Post, Aswin Ratheesh, et al.
BMC Medicine|January 26, 2019
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placeboMichael Berk, Alyna Turner, Gin S Malhi, et al.
BMC Medicine|February 18, 2019
Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placeboMichael Berk, Alyna Turner, Gin S Malhi, et al.
Early Intervention in Psychiatry|July 16, 2013
A randomized controlled trial of vocational intervention for young people with first-episode psychosis: methodEóin Killackey, Kelly Allott, Susan M Cotton, et al.
Pageof 5